Pfizer Inc.

News & Analysis

pfizer inc. - All News and Analysis

• Pfizer - Prempro: Kris Hundley writes

  BNET - 2009-11-20

  Is Prempro, the hormone drug known to increase the risk of breast cancer, a public hazard? If a judge in Pinellas County determines that it is, hundreds of thousands of documents now under seal in lawsuits against the drug's manufacturer nationwide could be released for the public to inspect. The...

  Tags: Wyeth, Breast Cancer, Pfizer Inc., Statute

• Pfizer Is Best Positioned Big Pharma in China - Goldman

  Seeking Alpha - 2009-11-20

  ChinaBio Today submits: In an investment review of Pfizer (NYSE: PFE), Goldman Sachs said sales in emerging growth markets would become a significant factor in the company’s revenues, a fact that it considers underappreciated by stock market investors. China is the major emerging market for Pfizer. Goldman expects...

  Tags: Healthcare, ChinaBio Today, Pfizer Inc.

• Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash

  BNET - 2009-11-19

  Merck MRK has produced a set of numbers giving a look at the scale of the combined company with Schering-Plough. One surprise: The new company is still just a little bit smaller than the old Pfizer PFE was. The new Merck would have had annual sales $46.7 billion, compared to...

  Tags: Pfizer Inc., Merck & Co. Inc., Sales Strategy, Sales Force Management, Sales, Jim Edwards

• Why Pfizer Wants Your Car-Sick Dog to Travel on Thanksgiving

  BNET - 2009-11-19

  Thanksgiving plus recession equals car sickness drugs for dogs, according to a new press release from Pfizer PFE. The company is urging people to bring their dogs with them as they travel for Thanksgiving dinner. Why? Because Pfizer makes a motion-sickness drug for dogs, Cerenia, so now there's no excuse...

  Tags: Car, Thanksgiving, Pfizer Inc., Dog, Jim Edwards

• Pfizer Scientist Stabbed Wife After Job Loss, Police Say

  BNET - 2009-11-18

  A former Pfizer PFE employee who lost his job and “was convinced he could not provide for his family any further,” has been charged with stabbing his wife, according to police. Pfizer is in the process of laying off 19,500 employees in its merger with Wyeth. Asbill was involved in...

  Tags: Job, Pfizer Inc., Job Loss, Recruitment & Selection, Mergers & Acquisitions, Human Resources, Workforce Management, Investment, Finance, Jim Edwards

• As Tax Breaks for Pfizer End, Jobs Disappear

  BNET - 2009-11-16

  As Pfizer PFE reorganizes after its merger with Wyeth, municipalities are finding that the tax deals they once struck to keep the drug giant in town are having short-term advantages at best and, at worst, no effect at all. Pfizer must make 19,500 layoffs across its empire to make the...

  Tags: Job, Merger, Pfizer Inc., Tax Break, Mergers & Acquisitions, Taxes, Free Trade, Personal Finance, Investment, Finance, Financial Planning, Jim Edwards

• Pfizer Tries Again for Sanctions Against Neurontin Witness

  BNET - 2009-11-13

  Pfizer PFE is playing hardball in its attempt to get sanctions applied to an expert in the Neurontin litigation who contacted another witness wthout the drug company's permission. The company is asking a judge to overturn the ruling of a federal magistrate that sanctions should not be applied to Dr....

  Tags: Sanction, Pfizer Inc., Litigation, Advertising & Promotion, Business Operations, Marketing, Jim Edwards

• Swinging The Ax At The Drug Companies - The Atlantic Business Channel

  BNET - 2009-11-12

  « The Senate Plan's Resolution Authority | Main | Does Excess Debt Lead to Bubbles? » Nov 11 2009, 11:15 am by Derek Lowe Swinging The Ax At The Drug Companies...

  Tags: Wyeth, Pfizer Inc., Drug Company

• Report: Company-funded studies of Pfizer epilepsy drug misleading | News from The Post-Standard -

  BNET - 2009-11-11

  Report: Company-funded studies of Pfizer epilepsy drug misleading By The Associated Press November 11, 2009, 8:16PM Mark Lennihan / The Associated Press, 2009The Pfizer world headquarters in New York. Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug...

  Tags: Pfizer Inc.

• Pfizer's Chemistry Head Count: Lower than Before the Wyeth Merger

  Seeking Alpha - 2009-11-11

  Derek Lowe submits: A reader who's unfortunately in a position to know the details sends along some numbers on Pfizer's PFE chemistry shakeout. According to his figures, Pfizer (pre-Wyeth merger) had about 900 chemists. The Wyeth deal brought in about 350, but no one expected the merged department to...

  Tags: Healthcare, Derek Lowe, Pfizer Inc.